AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31851667 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial standings at rounds 10, 20, and 30
Number of subjects: 22
Study 31851667 — intervention group
Group type: COMPARATOR
Intervention: Randomized leagues
Number of subjects: 22
Study 31851667 — intervention group
Group type: EXPERIMENTAL
Intervention: Reordering of match fixtures
Number of subjects: 22
Study 27787624 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane nasal dressing
Number of subjects: 30
Study 27787624 — intervention group
Group type: COMPARATOR
Intervention: No nasal packing (control)
Number of subjects: 30
Study 26787238 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomalidomide (4 mg daily, 21/28 versus 28/28) and dexamethasone
Number of subjects: 0
Study 24711779 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 84
Study 24711779 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulative therapy
Number of subjects: 84
Study 24711779 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of manual and manipulative therapy
Number of subjects: 84
Study 24711779 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study 22612596 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening with flexible sigmoidoscopy
Number of subjects: 154900
Study 20813580 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic physical activity plus sleep hygiene education
Number of subjects: 17
Study 20813580 — intervention group
Group type: COMPARATOR
Intervention: Non-physical activity plus sleep hygiene
Number of subjects: 17
Study 17664882 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical in appearance to vitamin E softgel)
Number of subjects: 51
Study 17664882 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU softgel cap)
Number of subjects: 51
Study 15827075 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care program in a community pharmacy
Number of subjects: 0
Study 15827075 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study 11574338 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced Fluid group (Hartmann's solution and 6% hetastarch in balanced electrolyte and glucose injection)
Number of subjects: 47
Study 11574338 — intervention group
Group type: COMPARATOR
Intervention: Saline group (0.9% sodium chloride solution and 6% hetastarch in 0.9% sodium chloride solution)
Number of subjects: 47
Study 11574338 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced Fluid group
Number of subjects: 47
Study 11574338 — intervention group
Group type: COMPARATOR
Intervention: Saline group
Number of subjects: 47
Study 9576119 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 5 or 20 mg BID
Number of subjects: 391
Study 9576119 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine 5 or 10 mg BID
Number of subjects: 391
Study 9576119 — intervention group
Group type: COMPARATOR
Intervention: Isradipine
Number of subjects: 391
Study 9576119 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 391
Study 9576119 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril and Isradipine
Number of subjects: 391
Study 8154647 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated-dose tissue plasminogen activator (tPA)
Number of subjects: 0
Study 8154647 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 0
Study 3278798 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A (intermittent regimen)
Number of subjects: 131
Study 3278798 — intervention group
Group type: COMPARATOR
Intervention: Regimen B (continuous regimen)
Number of subjects: 131
Study 29788288 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG-guided exclusion diet
Number of subjects: 97
Study 29788288 — intervention group
Group type: COMPARATOR
Intervention: Healthy diet (control)
Number of subjects: 97
Study 28078455 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic training
Number of subjects: 40
Study 28078455 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic training
Number of subjects: 40
Study 24343701 — intervention group
Group type: EXPERIMENTAL
Intervention: DE‐CTA‐MPR
Number of subjects: 21
Study 24343701 — intervention group
Group type: COMPARATOR
Intervention: CE‐MRA
Number of subjects: 21
Study 24343701 — intervention group
Group type: EXPERIMENTAL
Intervention: DE‐CTA‐PS‐MIP
Number of subjects: 21
Study 24343701 — intervention group
Group type: COMPARATOR
Intervention: DSA
Number of subjects: 21
Study 24252845 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA+DHA supplementation (0, 300, 600, 900, 1800 mg daily)
Number of subjects: 115
Study 24252845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 21143249 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 90
Study 21143249 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 90
Study 21143249 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 90
Study 18981939 — intervention group
Group type: EXPERIMENTAL
Intervention: GLU + CAF (6.4% glucose plus caffeine providing 5.3 mg kg(‐1) of caffeine)
Number of subjects: 10
Study 18981939 — intervention group
Group type: COMPARATOR
Intervention: GLU (6.4% glucose)
Number of subjects: 10
Study 18981939 — intervention group
Group type: COMPARATOR
Intervention: PLA (placebo)
Number of subjects: 10
Study 18981939 — intervention group
Group type: COMPARATOR
Intervention: GLU
Number of subjects: 10
Study 18981939 — intervention group
Group type: EXPERIMENTAL
Intervention: GLU + CAF
Number of subjects: 10
Study 18981939 — intervention group
Group type: COMPARATOR
Intervention: PLA
Number of subjects: 10
Study 16580527 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote magnetic navigation ablation using the NIOBE II system
Number of subjects: 40
Study 16580527 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote magnetic navigation ablation
Number of subjects: 40
Study 14634576 — intervention group
Group type: EXPERIMENTAL
Intervention: Presumptive treatment with azithromycin, cefixime, and metronidazole
Number of subjects: 206
Study 14634576 — intervention group
Group type: COMPARATOR
Intervention: No treatment for Trichomonas vaginalis
Number of subjects: 206
Study 10929693 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent transfer
Number of subjects: 15
Study 10929693 — intervention group
Group type: COMPARATOR
Intervention: Nurse transfer
Number of subjects: 15
Study 10929693 — intervention group
Group type: EXPERIMENTAL
Intervention: Both transfer methods
Number of subjects: 15
Study 9008498 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone 50 mg tid
Number of subjects: 151
Study 9008498 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone 200 mg tid
Number of subjects: 151
Study 9008498 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone 400 mg tid
Number of subjects: 151
Study 9008498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 7984589 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyostimulation (EMS) with adjuvant intravascular laser radiation of the blood (ILRB)
Number of subjects: 60
Study 7984589 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 60
Study 3297181 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular release (RR) quinidine sulfate
Number of subjects: 6
Study 3297181 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release (SR) quinidine bisulfate
Number of subjects: 6
Study 3297181 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release (SR) quinidine bisulfate with food (SR-F)
Number of subjects: 6
Study 3297181 — intervention group
Group type: EXPERIMENTAL
Intervention: All three dosage regimens (RR, SR, SR-F)
Number of subjects: 6
Study 3297181 — intervention group
Group type: COMPARATOR
Intervention: FPIA
Number of subjects: 6
Study 30845243 — intervention group
Group type: EXPERIMENTAL
Intervention: High inhibition demands condition (75% of incongruent trials)
Number of subjects: 134
Study 30845243 — intervention group
Group type: COMPARATOR
Intervention: Control condition (0% of incongruent trials)
Number of subjects: 134
Study 28272227 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% xenon
Number of subjects: 100
Study 28272227 — intervention group
Group type: COMPARATOR
Intervention: 50% oxygen (control group)
Number of subjects: 100
Study 24947057 — intervention group
Group type: EXPERIMENTAL
Intervention: Trisodium citrate (TSC)
Number of subjects: 207
Study 24947057 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 207
Study 23975663 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (oxaliplatin/FU) - Arm B
Number of subjects: 126
Study 23975663 — intervention group
Group type: COMPARATOR
Intervention: No induction chemotherapy - Arm A
Number of subjects: 126
Study 23975663 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 126
Study 21439823 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (80 mg/m² IV on days 1, 8, 15, 22, and 29) and uracil-tegafur (300 mg/m² TID from days 1-28) with folinic acid (90 mg QD)
Number of subjects: 31
Study 21439823 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel and uracil-tegafur
Number of subjects: 31
Study 19323672 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-feedback intervention to promote positive parenting (VIPP)
Number of subjects: 54
Study 19323672 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study 17366000 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC, n=18)
Number of subjects: 33
Study 17366000 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy (OC, n=15)
Number of subjects: 33
Study 15311838 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractal dimension (FD) of the skeletonized cerebral surface
Number of subjects: 62
Study 15311838 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumes of intracranial gray matter and white matter
Number of subjects: 62
Study 11743288 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose conformal radiation therapy (77.4 Gy delivered to the prostate)
Number of subjects: 167
Study 9521253 — intervention group
Group type: EXPERIMENTAL
Intervention: L-deprenyl (10 mg daily)
Number of subjects: 60
Study 9521253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 8194282 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetrexate
Number of subjects: 0
Study 8194282 — intervention group
Group type: COMPARATOR
Intervention: Cotrimoxazole (trimethoprim-sulfamethoxazole)
Number of subjects: 0
Study 2913547 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime or ceftriaxone therapy
Number of subjects: 301
Study 1096809 — intervention group
Group type: EXPERIMENTAL
Intervention: cephalothin-tobramycin
Number of subjects: 186
Study 1096809 — intervention group
Group type: EXPERIMENTAL
Intervention: cephalothin-ticarcillin
Number of subjects: 186
Study 1096809 — intervention group
Group type: EXPERIMENTAL
Intervention: ticarcillin-tobramycin
Number of subjects: 186
Study 1096809 — intervention group
Group type: EXPERIMENTAL
Intervention: ticarcillin-cephalothin
Number of subjects: 186
Study 762245 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen breathing during exercise
Number of subjects: 24
Study 762245 — intervention group
Group type: COMPARATOR
Intervention: Air breathing during exercise
Number of subjects: 24
Study 31766971 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression depth of 5 cm
Number of subjects: 400
Study 31766971 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression depth of 6 cm
Number of subjects: 400
Study 27928721 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 μg selenium supplements as tablet (n = 30)
Number of subjects: 60
Study 27928721 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 30)
Number of subjects: 60
Study 26162698 — intervention group
Group type: EXPERIMENTAL
Intervention: Labouring deliveries
Number of subjects: 5
Study 26162698 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal edge of the placenta
Number of subjects: 5
Study 26162698 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG3 and PEG10
Number of subjects: 5
Study 23951035 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% neutral oligosaccharides (scGOS/lcFOS) and 20% pectin-derived acidic oligosaccharides (pAOS)
Number of subjects: 113
Study 23951035 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 113
Study 20540083 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy (CBT)
Number of subjects: 44
Study 18986646 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 703
Study 18986646 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 703
Study 17267841 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal fibronectin levels at 28 weeks
Number of subjects: 2353
Study 17267841 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal fibronectin levels at 20-24 weeks
Number of subjects: 2353
Study 17267841 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic treatment at 20-24 weeks
Number of subjects: 2353
Study 15541252 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide (glycoprotein IIb/IIIa platelet receptor inhibitor) for 24 hours
Number of subjects: 50
Study 15541252 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study 11941231 — intervention group
Group type: EXPERIMENTAL
Intervention: Amukine 0.06% solution
Number of subjects: 113
Study 11941231 — intervention group
Group type: COMPARATOR
Intervention: Povidone iodine (Bétadine) 5% solution
Number of subjects: 113
Study 10230996 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal fluency task during walking in PD-F patients
Number of subjects: 38
Study 10230996 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiparkinsonian medications in PD-F patients
Number of subjects: 38
Study 10230996 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 38
Study 8706117 — intervention group
Group type: EXPERIMENTAL
Intervention: sumatriptan
Number of subjects: 268
Study 8706117 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 268
Study 2568349 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritanserin
Number of subjects: 8
Study 2568349 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 8
Study 14652 — intervention group
Group type: EXPERIMENTAL
Intervention: Carpipramine (3 X 100 mg daily for 43 days)
Number of subjects: 60
Study 14652 — intervention group
Group type: EXPERIMENTAL
Intervention: Carpipramine (30 days)
Number of subjects: 60
Study 14652 — intervention group
Group type: COMPARATOR
Intervention: Doxepine (30 days)
Number of subjects: 60
Study 31998802 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-CpG-based signature model
Number of subjects: 371
Study 30977382 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycra® gauntlets for eight hours daily for eight weeks, plus usual rehabilitation (n=27)
Number of subjects: 43
Study 30977382 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation only (n=16)
Number of subjects: 43
Study 29270521 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 961
Study 29270521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 961
Study 26283085 — intervention group
Group type: COMPARATOR
Intervention: Olodaterol 20 μg
Number of subjects: 494
Study 26283085 — intervention group
Group type: COMPARATOR
Intervention: Olodaterol 2 μg
Number of subjects: 494
Study 26283085 — intervention group
Group type: COMPARATOR
Intervention: Olodaterol 5 μg
Number of subjects: 494
Study 26283085 — intervention group
Group type: COMPARATOR
Intervention: Olodaterol 10 μg
Number of subjects: 494
Study 26283085 — intervention group
Group type: COMPARATOR
Intervention: Formoterol 12 μg twice-daily
Number of subjects: 494
Study 23443830 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-month core foods (fruit, grains, vegetables, cheese, nuts/seeds)
Number of subjects: 1045
Study 23443830 — intervention group
Group type: EXPERIMENTAL
Intervention: basic combination (white bread, milk, spreads, juice, ice-cream)
Number of subjects: 1045
Study 23443830 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-month core foods (fruit, vegetables, dairy, nuts/seeds, meat, water)
Number of subjects: 1045
Study 23443830 — intervention group
Group type: EXPERIMENTAL
Intervention: non-core foods (white bread, spreads, sweetened beverages, snacks, chocolate, processed meat)
Number of subjects: 1045
Study 23443830 — intervention group
Group type: COMPARATOR
Intervention: Maternal age and breastfeeding cessation
Number of subjects: 1045
Study 23443830 — intervention group
Group type: COMPARATOR
Intervention: Solid food introduction timing
Number of subjects: 1045
Study 23443830 — intervention group
Group type: COMPARATOR
Intervention: Body mass index (BMI) z-score
Number of subjects: 1045
Study 22188781 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional home-based exercise programme delivered by an exercise therapist over 12 weeks.
Number of subjects: 210
Study 22188781 — intervention group
Group type: COMPARATOR
Intervention: Baseline physical activities (control group).
Number of subjects: 210
Study 22188781 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional home-based exercise programme.
Number of subjects: 210
Study 19694864 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal glasses
Number of subjects: 30
Study 19694864 — intervention group
Group type: COMPARATOR
Intervention: Single-lens glasses
Number of subjects: 30
Study 16509105 — intervention group
Group type: EXPERIMENTAL
Intervention: Right‐Brain Damaged (RBD) patients
Number of subjects: 12
Study 16509105 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 12
Study 15564707 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard plus exercise at a fitness club (2-4 times per week)
Number of subjects: 561
Study 15564707 — intervention group
Group type: COMPARATOR
Intervention: National standard alone (control)
Number of subjects: 561
Study 11773207 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH)
Number of subjects: 125
Study 11773207 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 125
Study 11773207 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone + Testosterone (GH + T)
Number of subjects: 125
Study 11773207 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) + HRT
Number of subjects: 125
Study 11773207 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (T)
Number of subjects: 125
Study 9561680 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin (CyA, n = 14)
Number of subjects: 27
Study 9561680 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (n = 13)
Number of subjects: 27
Study 9561680 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone treatment (more prevalent in CyA-treated patients)
Number of subjects: 27
Study 9561680 — intervention group
Group type: COMPARATOR
Intervention: Healthy matched controls (n = 20)
Number of subjects: 27
Study 8079602 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood velocimetry of the fetal descending aorta, umbilical artery and vein, and the maternal arcuate artery using 2.5 MHz pulsed wave Doppler ultrasound; Histological examination of at least five random samples from each placenta
Number of subjects: 37
Study 2722224 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydrocortisone (200 mg/day for 1 week)
Number of subjects: 8
Study 55717 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazoxide 5 mg/kg/day for 7 days with insulin
Number of subjects: 14
Study 55717 — intervention group
Group type: COMPARATOR
Intervention: Placebo with insulin
Number of subjects: 14
Study 31878111 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine fact sheet
Number of subjects: 756
Study 31878111 — intervention group
Group type: COMPARATOR
Intervention: Control messages (bottled water ads)
Number of subjects: 756
Study 29850571 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow desflurane (Group I)
Number of subjects: 90
Study 29850571 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow desflurane (Group II)
Number of subjects: 90
Study 29850571 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow TIVA (propofol, remifentanil) (Group III)
Number of subjects: 90
Study 26738470 — intervention group
Group type: EXPERIMENTAL
Intervention: Education on symptoms management based on training modifications
Number of subjects: 69
Study 26738470 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program targeting lower limb strengthening and control in addition to education
Number of subjects: 69
Study 26738470 — intervention group
Group type: EXPERIMENTAL
Intervention: Running gait retraining advice in addition to education
Number of subjects: 69
Study 26738470 — intervention group
Group type: COMPARATOR
Intervention: All groups (Education, Exercise, Gait retraining)
Number of subjects: 69
Study 25298894 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical menthol (Biofreeze)
Number of subjects: 10
Study 25298894 — intervention group
Group type: COMPARATOR
Intervention: Placebo (gel with a menthol scent)
Number of subjects: 10
Study 22283697 — intervention group
Group type: EXPERIMENTAL
Intervention: Apical negative pressure (ANP) irrigation
Number of subjects: 70
Study 22283697 — intervention group
Group type: COMPARATOR
Intervention: Positive pressure
Number of subjects: 70
Study 22283697 — intervention group
Group type: COMPARATOR
Intervention: SAF without pecking motion
Number of subjects: 70
Study 22283697 — intervention group
Group type: COMPARATOR
Intervention: SAF with pecking motion
Number of subjects: 70
Study 20302001 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 142
Study 20302001 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous surgery
Number of subjects: 142
Study 17413246 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents
Number of subjects: 0
Study 17413246 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 0
Study 16148057 — intervention group
Group type: EXPERIMENTAL
Intervention: Photopheresis
Number of subjects: 10
Study 16148057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10